🇺🇸 FDA
Patent

US 11524053

Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents

granted A61KA61K38/00A61K38/179

Quick answer

US patent 11524053 (Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents) held by The Regents of the University of California expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00, A61K38/179, A61K9/0019, A61K9/0048